Learn

Gynaecological Cancer Research Review Issue 17 with commentary by Dr Geraldine Goss.  

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in gynaecological cancer. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

Details

In this issue we feature:
  -  Endometriosis & ovarian cancer risk
  -  Obstetric outcomes in survivors of adolescent/young adult cancer
  -  SABR for oligometastatic & oligoprogressive gynaecological tumours
  -  LACC: minimally invasive vs. open radical hysterectomy for early-stage cervical cancer
  -  Radiation ± cisplatin for recurrent endometrial cancer
  -  Genomic relatedness of concurrent endometrial & ovarian carcinomas
  -  RAS mutations in gynaecologic cancers
  -  RUBY: dostarlimab + carboplatin-paclitaxel in endometrial cancer
  -  Apixaban vs. enoxaparin in gynaecological cancer surgery
  -  Epacadostat (IDO1 inhibitor) in recurrent OCCC

To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.